14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CORZZ vs CORZW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Core Scientific, Inc. Tranche 2 Warrants (CORZZ) is the stronger overall head-to-head candidate over Core Scientific, Inc. Tranche 1 Warrants (CORZW) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CORZZ carries a Unified Composite Score of 34.3/100 (SELL) at $13.44 (N/M Forward P/E, N/A operating margin), whereas CORZW carries 40.1/100 (SELL) at $6.76 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While CORZW currently prints a higher short-term Unified Composite Score (40.1/100 SELL vs. CORZZ 34.3/100 SELL), CORZZ captures the overall institutional head-to-head verdict (1–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Defensive Composite Rating Caution: Although CORZZ compares more favorably head-to-head, both CORZZ (34.3/100 SELL) and CORZW (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CORZZ vs CORZW. Trailing 12-month operating profitability (CORZZ N/A vs CORZW N/A) and valuation multiples (CORZZ N/M vs CORZW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Finance Services value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CORZZ vs CORZW Key Questions & Quantitative Answers
As of Nov 16, 2026, Core Scientific, Inc. Tranche 2 Warrants (CORZZ) is the stronger overall head-to-head candidate over Core Scientific, Inc. Tranche 1 Warrants (CORZW) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CORZZ carries a Unified Composite Score of 34.3/100 (SELL) at $13.44 (N/M Forward P/E, N/A operating margin), whereas CORZW carries 40.1/100 (SELL) at $6.76 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While CORZW currently prints a higher short-term Unified Composite Score (40.1/100 SELL vs. CORZZ 34.3/100 SELL), CORZZ captures the overall institutional head-to-head verdict (1–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Defensive Composite Rating Caution: Although CORZZ compares more favorably head-to-head, both CORZZ (34.3/100 SELL) and CORZW (40.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
CORZZ and CORZW split Growth & Scale metrics: CORZZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CORZW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CORZZ generates N/A in USD-normalized revenue versus N/A for CORZW. In operating R&D and SG&A reinvestment, CORZZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CORZW.
CORZZ and CORZW trade at balanced relative valuation multiples. CORZZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CORZW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CORZZ (N/A ROE) versus CORZW (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, CORZZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.88β · 102% Vol realized risk). By comparison, CORZW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.76β · 216% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.